Laddar...
L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review
Lung cancer is one of the most prevalent malignancies worldwide and the leading cause of cancer-related death. Most cases are non-small cell lung cancer (NSCLC). The median overall survival of patients with advanced stage undergoing current standard chemotherapy is approximately 10 months. The addit...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Pioneer Bioscience Publishing Company
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215136/ https://ncbi.nlm.nih.gov/pubmed/25364531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.08.17 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|